WATCH: Guest Passes Out During Oval Office Announcement, Dr. Oz Springs Into Action

A tense moment unfolded inside the Oval Office on Thursday when a guest suddenly collapsed during President Donald Trump’s announcement on lowering drug prices — prompting swift action from Dr. Mehmet Oz and others in attendance.

The incident occurred as the president’s team was delivering remarks alongside top health officials and pharmaceutical executives during an event focused on obesity treatments and prescription drug costs. Cameras were rolling when the man appeared to lose balance before falling, causing a brief panic in the room.

“Are you OK? Gordon, you OK?” asked Eli Lilly CEO David Ricks as the man began to slump over. President Trump, seated at the Resolute Desk, immediately rose to his feet as aides and attendees rushed to assist.

Among them was Dr. Mehmet Oz, the well-known surgeon and television personality who currently serves as Trump’s administrator for the Centers for Medicare & Medicaid Services. Oz quickly moved toward the fallen guest, kneeling beside him to assess his condition as others cleared the area.

“Press out!” someone shouted, and reporters were ushered out of the room as the cameras were abruptly cut.

WATCH:

According to White House press secretary Karoline Leavitt, the man—identified as a representative from one of the companies attending—was treated immediately by the White House Medical Unit and is expected to be fine.

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted,” Leavitt said in a statement. “The White House Medical Unit quickly jumped into action, and the gentleman is okay. The press conference will resume shortly.”

The event featured executives from pharmaceutical companies including Eli Lilly and Novo Nordisk, both of which produce some of the country’s most well-known obesity and diabetes medications such as Ozempic and Wegovy. Initially, speculation spread online identifying the man as Gordon Findlay, an executive with Novo Nordisk. However, the company later clarified that Findlay was not present.

“We hope the gentleman who suffered a medical incident today is okay,” a Novo Nordisk spokesperson said, adding that only CEO Mike Doustdar and Executive Vice President Dave Moore were in attendance.

The man who fainted did not return to the Oval Office once the event resumed. The cause of the collapse was not immediately known, though such incidents are not uncommon during lengthy, high-profile gatherings under hot lights and crowded conditions.

President Trump announced new agreements aimed at cutting the cost of widely used weight-loss medications, as his administration focuses on making healthcare more affordable. Many GLP-1 drugs—prescribed for diabetes and obesity—can exceed $1,000 a month without insurance or discounts.

Under the new deals, Eli Lilly and Novo Nordisk will gain expanded access to Medicare and Medicaid, the federal health programs serving seniors and low-income Americans.

The White House’s “Most Favored Nations” announcement centered on a new initiative aimed at lowering drug prices by promoting competition and encouraging greater access to obesity treatments. The administration has stressed reducing costs for life-saving medications, with Trump saying the move represents a major step toward fairness for American patients.

Also speaking at the event, Health Secretary Robert F. Kennedy Jr. noted the complex relationship between health outcomes and economic inequality.

“Obesity is a disease of poverty,” Kennedy said, referencing data from the Centers for Disease Control and Prevention showing that roughly 44 percent of adults with the lowest incomes are affected.